By forging new relationships and finding novel uses for existing technologies, this year’s top companies are employing creative ways to advance their science.

Samantha Maragh has taken on the difficult challenge of standardizing assays, data norms, and terminology in the ever evolving genome editing field.

This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.

Genome Author: Holly Ahern SIDEBAR: Selected Suppliers of DNA Sequencing Equipment and Supplies Since the Human Genome Project (HGP) was launched five years ago, human geneticists working to decipher the code of nucleotides in the DNA of human cells have enthralled the public with discoveries of numerous genes that are responsible for human diseases, such as cancer-related genes. Different groups of scientists in laboratories all over the world are participating in this project, taking apart t

From a mass photometer to improved breath biopsy probes, these new products are poised for scientific success.

The newest life-science products making waves in labs and clinics

The Ni-NTA spin columns provide purification of 6xHis-tagged proteins from small-scale expression cultures. Available in two formats--separately without reagents or as a complete kit--they can be used in experimental situations requiring small-scale expression, functional screening, and rapid purification of engineered and recombinant proteins. Each can purify up to 100 fg of 6xHis tagged protein under native or denaturing conditions. According to the manufacturer, this procedure allows 12 mini

And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo

Date : December 12, 1994 Incensed that the terms exclude industrial scientists, Merck announces sponsorship of competing project A powerful new, privately held database of human complementary DNA (cDNA) sequences has become available to researchers eager to test its capabilities to rapidly identify new genes. The proposed terms of access to the database, however, exclude pharmaceutical and other industry-affiliated scientists, an

Date : December 12, 1994 Incensed that the terms exclude industrial scientists, Merck announces sponsorship of competing project A powerful new, privately held database of human complementary DNA (cDNA) sequences has become available to researchers eager to test its capabilities to rapidly identify new genes. The proposed terms of access to the database, however, exclude pharmaceutical and other industry-affiliated scientists, an